Drug Shortage Report for ONCASPAR
Report ID | 181357 |
Drug Identification Number | 02461900 |
Brand name | ONCASPAR |
Common or Proper name | Injection de pegaspargase |
Company Name | SERVIER CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PEGASPARGASE |
Strength(s) | 750UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 5ml |
ATC code | L01XX |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-02-20 |
Actual start date | |
Estimated end date | 2024-02-29 |
Actual end date | 2024-02-29 |
Shortage status | Resolved |
Updated date | 2024-03-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3224 AVENUE JEAN-BÉRAUD LAVAL, QUEBEC CANADA H7T 2S4 |
Company contact information | Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4 Phone : (450) 978-9700 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-01-17 | French | Compare |
v1 | 2023-01-17 | English | Compare |